These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35576314)

  • 21. Consolidation in the Electronic Health Record Market, 2009-2017.
    Mandeville B; Rahman M; Gardner RL
    R I Med J (2013); 2020 Aug; 103(6):75-79. PubMed ID: 32752573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Provider Practice Competition and Adoption of Medicare's Oncology Care Model.
    Jalali A; Martin C; Nelson RE; Vanneman ME; Martin BI; Cooney KA; Waitzman NJ; O'Neil B
    Med Care; 2020 Feb; 58(2):154-160. PubMed ID: 31688568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pharmaceutical market in Mexico: size, value, and concentration].
    Torres Guerra S; Gutiérrez JP
    Rev Panam Salud Publica; 2009 Jul; 26(1):46-50. PubMed ID: 19814881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician Competition in the Era of Accountable Care Organizations.
    Richards MR; Smith CT; Graves AJ; Buntin MB; Resnick MJ
    Health Serv Res; 2018 Apr; 53(2):1272-1285. PubMed ID: 28345256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of hospital market competition on endovascular aneurysm repair adoption and outcomes.
    Sethi RK; Henry AJ; Hevelone ND; Lipsitz SR; Belkin M; Nguyen LL
    J Vasc Surg; 2013 Sep; 58(3):596-606. PubMed ID: 23684424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Market Consolidation and Mortality in Patients Initiating Hemodialysis.
    Erickson KF; Winkelmayer WC; Ho V; Bhattacharya J; Chertow GM
    Value Health; 2019 Jan; 22(1):69-76. PubMed ID: 30661636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition.
    Zhang JX
    PLoS One; 2020; 15(6):e0234463. PubMed ID: 32525965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dialogue. Industry consolidation: what's at stake for consumers and purchasers?
    Greenberg W; Allen J; Wider JJ; Ray CG
    Behav Healthc Tomorrow; 1998 Aug; 7(4):32-8. PubMed ID: 10182151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focusing on economic realities can advance hospital mergers.
    Ettinger DA
    Health Prog; 1988 Oct; 69(8):52-4, 70. PubMed ID: 10290387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMO consolidations: how national mergers affect local markets.
    Feldman RD; Wholey DR; Christianson JB
    Health Aff (Millwood); 1999; 18(4):96-104. PubMed ID: 10425846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician practice competition and prices paid by private insurers for office visits.
    Baker LC; Bundorf MK; Royalty AB; Levin Z
    JAMA; 2014 Oct 22-29; 312(16):1653-62. PubMed ID: 25335147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process.
    Wong ASY; Cole CB; Kohler JC
    Global Health; 2021 Aug; 17(1):92. PubMed ID: 34416883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
    Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
    J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisiting the relationship between managed care and hospital consolidation.
    Town RJ; Wholey D; Feldman R; Burns LR
    Health Serv Res; 2007 Feb; 42(1 Pt 1):219-38. PubMed ID: 17355590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Rise Of Cross-Market Hospital Systems And Their Market Power In The US.
    Fulton BD; Arnold DR; King JS; Montague AD; Greaney TL; Scheffler RM
    Health Aff (Millwood); 2022 Nov; 41(11):1652-1660. PubMed ID: 36343312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Orthopedic Surgeon Practice Consolidation From 2008 to 2019.
    Henretty KN; He F
    J Arthroplasty; 2022 Mar; 37(3):409-413. PubMed ID: 34780926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mega-mergers in the pharmaceutical industry. In whose interests?
    Po AL
    Pharmacoeconomics; 1998 Oct; 14(4):349-55. PubMed ID: 10344903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitrust and hospital mergers: does the nonprofit form affect competitive substance?
    Greaney TL
    J Health Polit Policy Law; 2006 Jun; 31(3):511-29. PubMed ID: 16785295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacit collusion among hospitals in price competitive markets.
    Mobley LR
    Health Econ; 1996; 5(3):183-93. PubMed ID: 8817294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doubts emerge about drug industry mergers.
    Bus Health; 1994 Nov; 12(11):53-4, 56, 61. PubMed ID: 10138536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.